ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/31 | 3,275 | 3,290 | 3,195 | 3,200 | -120 | -3.6% | 175,100 |
| 2022/03/30 | 3,390 | 3,415 | 3,270 | 3,320 | -95 | -2.8% | 149,000 |
| 2022/03/29 | 3,370 | 3,415 | 3,365 | 3,415 | +40 | +1.2% | 113,700 |
| 2022/03/28 | 3,425 | 3,425 | 3,370 | 3,375 | -50 | -1.5% | 54,500 |
| 2022/03/25 | 3,415 | 3,430 | 3,385 | 3,425 | +55 | +1.6% | 92,500 |
| 2022/03/24 | 3,390 | 3,415 | 3,330 | 3,370 | -30 | -0.9% | 103,400 |
| 2022/03/23 | 3,330 | 3,430 | 3,310 | 3,400 | +110 | +3.3% | 140,800 |
| 2022/03/22 | 3,350 | 3,350 | 3,280 | 3,290 | -60 | -1.8% | 129,000 |
| 2022/03/18 | 3,385 | 3,405 | 3,335 | 3,350 | -35 | -1% | 118,000 |
| 2022/03/17 | 3,440 | 3,445 | 3,360 | 3,385 | -25 | -0.7% | 122,800 |
| 2022/03/16 | 3,435 | 3,495 | 3,390 | 3,410 | ±0 | ±0% | 144,700 |
| 2022/03/15 | 3,360 | 3,430 | 3,360 | 3,410 | +55 | +1.6% | 113,300 |
| 2022/03/14 | 3,335 | 3,395 | 3,315 | 3,355 | +35 | +1.1% | 95,900 |
| 2022/03/11 | 3,295 | 3,355 | 3,285 | 3,320 | -10 | -0.3% | 154,400 |
| 2022/03/10 | 3,285 | 3,345 | 3,260 | 3,330 | +155 | +4.9% | 128,200 |
| 2022/03/09 | 3,165 | 3,190 | 3,110 | 3,175 | -25 | -0.8% | 198,700 |
| 2022/03/08 | 3,165 | 3,220 | 3,150 | 3,200 | +25 | +0.8% | 210,100 |
| 2022/03/07 | 3,160 | 3,200 | 3,130 | 3,175 | -30 | -0.9% | 103,700 |
| 2022/03/04 | 3,235 | 3,240 | 3,190 | 3,205 | -5 | -0.2% | 105,000 |
| 2022/03/03 | 3,175 | 3,235 | 3,160 | 3,210 | +75 | +2.4% | 85,100 |
| 2022/03/02 | 3,175 | 3,200 | 3,130 | 3,135 | -55 | -1.7% | 89,200 |
| 2022/03/01 | 3,190 | 3,220 | 3,175 | 3,190 | ±0 | ±0% | 106,100 |
| 2022/02/28 | 3,110 | 3,200 | 3,110 | 3,190 | +105 | +3.4% | 118,600 |
| 2022/02/25 | 3,110 | 3,135 | 3,065 | 3,085 | -60 | -1.9% | 130,400 |
| 2022/02/24 | 3,085 | 3,150 | 3,070 | 3,145 | -10 | -0.3% | 109,600 |
| 2022/02/22 | 3,175 | 3,175 | 3,145 | 3,155 | -40 | -1.3% | 71,500 |
| 2022/02/21 | 3,195 | 3,215 | 3,175 | 3,195 | -55 | -1.7% | 71,000 |
| 2022/02/18 | 3,240 | 3,270 | 3,225 | 3,250 | -10 | -0.3% | 66,600 |
| 2022/02/17 | 3,310 | 3,310 | 3,245 | 3,260 | -60 | -1.8% | 61,600 |
| 2022/02/16 | 3,270 | 3,330 | 3,255 | 3,320 | +50 | +1.5% | 118,600 |
| 2022/02/15 | 3,255 | 3,290 | 3,240 | 3,270 | -10 | -0.3% | 88,700 |
| 2022/02/14 | 3,250 | 3,290 | 3,220 | 3,280 | -55 | -1.6% | 87,100 |
| 2022/02/10 | 3,340 | 3,370 | 3,310 | 3,335 | +15 | +0.5% | 109,000 |
| 2022/02/09 | 3,345 | 3,345 | 3,295 | 3,320 | -20 | -0.6% | 71,600 |
| 2022/02/08 | 3,360 | 3,425 | 3,325 | 3,340 | -20 | -0.6% | 66,100 |
| 2022/02/07 | 3,200 | 3,390 | 3,190 | 3,360 | +105 | +3.2% | 170,200 |
| 2022/02/04 | 3,235 | 3,280 | 3,195 | 3,255 | +20 | +0.6% | 105,600 |
| 2022/02/03 | 3,185 | 3,265 | 3,185 | 3,235 | -10 | -0.3% | 115,700 |
| 2022/02/02 | 3,190 | 3,250 | 3,180 | 3,245 | +30 | +0.9% | 100,600 |
| 2022/02/01 | 3,215 | 3,260 | 3,205 | 3,215 | -30 | -0.9% | 56,900 |
| 2022/01/31 | 3,185 | 3,255 | 3,185 | 3,245 | -10 | -0.3% | 57,400 |
| 2022/01/28 | 3,215 | 3,270 | 3,215 | 3,255 | +65 | +2% | 76,000 |
| 2022/01/27 | 3,290 | 3,305 | 3,155 | 3,190 | -105 | -3.2% | 139,100 |
| 2022/01/26 | 3,330 | 3,335 | 3,295 | 3,295 | -25 | -0.8% | 47,300 |
| 2022/01/25 | 3,360 | 3,360 | 3,245 | 3,320 | -55 | -1.6% | 94,100 |
| 2022/01/24 | 3,300 | 3,380 | 3,295 | 3,375 | +90 | +2.7% | 73,000 |
| 2022/01/21 | 3,315 | 3,330 | 3,255 | 3,285 | -10 | -0.3% | 99,100 |
| 2022/01/20 | 3,245 | 3,325 | 3,245 | 3,295 | +25 | +0.8% | 53,500 |
| 2022/01/19 | 3,345 | 3,375 | 3,255 | 3,270 | -80 | -2.4% | 101,200 |
| 2022/01/18 | 3,375 | 3,390 | 3,345 | 3,350 | -5 | -0.1% | 48,600 |
651～
700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ペプチド | 273,800円 | +56.7% | +357.2% | 0.00% | 25.35倍 | 6.04倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
